Geuking Markus B, Weber Jacqueline, Dewannieux Marie, Gorelik Elieser, Heidmann Thierry, Hengartner Hans, Zinkernagel Rolf M, Hangartner Lars
Institute of Experimental Immunology, University Hospital Zürich, Schmelzbergstrasse 12, 8091 Zürich, Switzerland.
Science. 2009 Jan 16;323(5912):393-6. doi: 10.1126/science.1167375.
Retroviruses have the potential to acquire host cell-derived genetic material during reverse transcription and can integrate into the genomes of larger, more complex DNA viruses. In contrast, RNA viruses were believed not to integrate into the host's genome under any circumstances. We found that illegitimate recombination between an exogenous nonretroviral RNA virus, lymphocytic choriomeningitis virus, and the endogenous intracisternal A-type particle (IAP) retrotransposon occurred and led to reverse transcription of exogenous viral RNA. The resulting complementary DNA was integrated into the host's genome with an IAP element. Thus, RNA viruses should be closely scrutinized for any capacity to interact with endogenous retroviral elements before their approval for therapeutic use in humans.
逆转录病毒在逆转录过程中有可能获取宿主细胞来源的遗传物质,并可整合到更大、更复杂的DNA病毒的基因组中。相比之下,人们曾认为RNA病毒在任何情况下都不会整合到宿主基因组中。我们发现,一种外源性非逆转录RNA病毒——淋巴细胞性脉络丛脑膜炎病毒,与内源性脑内A 型颗粒(IAP)逆转座子之间发生了异常重组,并导致外源性病毒RNA的逆转录。由此产生的互补DNA与一个IAP元件一起整合到了宿主基因组中。因此,在批准RNA病毒用于人类治疗之前,应仔细审查其与内源性逆转录病毒元件相互作用的任何能力。